arginine vasopressin has been researched along with pentagastrin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Drüge, G; Lenz, HJ | 1 |
Brown, MR; Hester, SE; Lenz, HJ | 1 |
Abelson, JL; Bichet, DG; Le Mellédo, J | 1 |
1 review(s) available for arginine vasopressin and pentagastrin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for arginine vasopressin and pentagastrin
Article | Year |
---|---|
Dose response of arginine vasopressin to the CCK-B agonist pentagastrin.
Topics: Adolescent; Adult; Analysis of Variance; Arginine Vasopressin; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Pentagastrin; Receptor, Cholecystokinin B; Receptors, Cholecystokinin | 2001 |
2 other study(ies) available for arginine vasopressin and pentagastrin
Article | Year |
---|---|
Neurohumoral pathways mediating stress-induced inhibition of gastric acid secretion in rats.
Topics: Adrenal Glands; Animals; Arginine Vasopressin; Bretylium Tosylate; Chlorisondamine; Corticotropin-Releasing Hormone; Ganglia, Sympathetic; Gastric Acid; Male; Naloxone; Neural Pathways; Neurotransmitter Agents; Pentagastrin; Pituitary Gland; Rats; Rats, Inbred Strains; Stress, Physiological; Vagus Nerve | 1990 |
Corticotropin-releasing factor. Mechanisms to inhibit gastric acid secretion in conscious dogs.
Topics: Animals; Arginine Vasopressin; Autonomic Nervous System; Chlorisondamine; Corticotropin-Releasing Hormone; Dogs; Eating; Gastric Acid; Gastrins; Male; Naloxone; Pentagastrin; Vagotomy; Vasopressins | 1985 |